ALS Delivers 'Solid' Fiscal H1 With Both Segments Beating Estimates, Says Jefferies
MT Newswires Live
Nov 18, 2025
ALS (ASX:ALQ) delivered a "solid" fiscal first half of 2026 with both segments, commodities and life sciences, beating Jefferies' estimate by 1% and 4%, respectively, said the investment firm in a Monday note.
The company reported Tuesday that its underlying earnings per share in the fiscal first half rose to AU$0.355 from AU$0.313 a year earlier. Revenue for the period was AU$1.66 billion, up from AU$1.46 billion last year.
Jefferies said that the only disappointment was the life sciences fiscal 2026 organic revenue growth outlook, which was lowered to 4% to 6% from 5% to 7%.
Jefferies kept a hold rating on ALS with a price target of AU$23.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.